Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials

Completed

Conditions studied: Multiple Sclerosis

In brief

Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants who Have Participated in Cladribine Clinical Trials

Key facts

Study ID

NCT01013350

Run by

EMD Serono

People needed

1161

Starts

2009-11-30

Expected to finish

2018-10-25

Last updated by the study team

2019-11-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Prior enrollment into selected oral cladribine clinical trials as of randomization to either study drug or placebo, once participation in the clinical trial has ended
• Written informed consent was given

You may not qualify if…

• Participants who cannot be reached by telephone
• Participants unable to answer the registry questionnaires and who do not have a next of kin or caregiver able to answer the registry questionnaires
• Participants who - either during the lag interval or subsequently enter an interventional study

Where it is running

• Outcome Sciences, Inc — Cambridge, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.